Clinical Trials Logo

Filter by:
NCT ID: NCT06062563 Not yet recruiting - Clinical trials for Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

Start date: November 11, 2023
Phase: N/A
Study type: Interventional

This study aims to observe and explore the efficacy and safety of Anlotinib combined with penpulimab in the treatment of radioiodine refractory differentiated thyroid cancer with first-line resistance to angiogenesis inhibitors, and to summarize the treatment experience of population.

NCT ID: NCT06062550 Not yet recruiting - Dexmedetomidine Clinical Trials

Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery

Start date: October 2023
Phase: Phase 4
Study type: Interventional

Scoliosis correction surgery is associated with severe pain. Patients after scoliosis correction surgery usually require high dose opioids and long duration analgesia, which may increase side effects and drug tolerance. In a recent trial, mini-dose esketamine and dexmedetomidine combination as a supplement to sufentanil significantly improved analgesia and subjective sleep quality after spinal correction surgery without increasing adverse events; however, the proportion of patients with moderate-to-severe pain remained high. The authors speculate that increasing esketamine dose in the combination may further improve analgesic effects.

NCT ID: NCT06060483 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 2

Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis

Start date: January 2024
Phase: N/A
Study type: Interventional

Patients with type 2 diabetes and moderate to severe coronary artery stenosis who were treated at Zhejiang Second Hospital and cooperative hospitals were randomly divided into a patient management group based on continuous continuous glucose monitoring (CGM) or a patient management group based on HbA1c. Both groups controlled cardiovascular risk factors according to the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020) and the ADA Guidelines for the Prevention and Treatment of Diabetes (2023), and conducted HbA1c testing every 3 months. In the CGM-based glucose management group, CGM measurements will be performed at baseline and at 6, 12, 18, and 24 months. In the CGM-guided treatment group, the target TIR>70%, TBR<4%, TAR<25%, and HbA1c<7.0%; in the HbA1c-guided treatment group, the target HbA1c<7.0%. The primary endpoint was major adverse cardiovascular events (MACE: CV death, nonfatal myocardial infarction, nonfatal stroke).

NCT ID: NCT06058546 Not yet recruiting - Plaque Psoriasis Clinical Trials

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

Start date: October 2023
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy and safety of Jiuweihuaban Pill in the treatment of moderate to severe plaque psoriasis(syndrome of blood-heat ).

NCT ID: NCT06058000 Not yet recruiting - Atopic Dermatitis Clinical Trials

A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis

Start date: October 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess efficacy, safety, and pharmacokinetics (PK) of QLM3003 Ointment in participants with mild or moderate atopic dermatitis.

NCT ID: NCT06056804 Not yet recruiting - Clinical trials for Locally Advanced Rectal Cancer

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Start date: December 1, 2023
Phase: Phase 2
Study type: Interventional

This is an open, prospective, multi-center, single-arm phase II clinical study assessing the efficacy and safety of neoadjuvant chemoradiotherapy combined with PD-1 inhibitor and thymalfasin in patients with pMMR/MSS locally advanced middle and low rectal cancer.

NCT ID: NCT06056232 Not yet recruiting - Emotional Distress Clinical Trials

Mechanisms of Mindfulness Intervention: Distress Tolerance Dose Manipulation

Start date: October 5, 2023
Phase: N/A
Study type: Interventional

This study hopes to: 1. explore whether an increase in the dosage of distress tolerance intervention corresponds to greater effectiveness of mindfulness intervention in alleviating emotional distress. 2. explore whether distress tolerance mediates the effects of mindfulness intervention on alleviating emotional distress.

NCT ID: NCT06054191 Not yet recruiting - NSCLC Clinical Trials

Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations

Start date: February 1, 2024
Phase: Phase 2
Study type: Interventional

This is a Phase II, two parallel group study assessing the efficacy and safety of neoadjuvant and adjuvant targeted therapy in patients with stage IB-IIIA NSCLC harboring BRAF V600 or MET exon14 mutations.

NCT ID: NCT06054087 Not yet recruiting - Clinical trials for Diabetic Peripheral Neuropathic Pain

Effectiveness of Electroacupuncture in the Treatment of Diabetic Peripheral Neuropathy

Start date: October 2023
Phase: N/A
Study type: Interventional

Diabetic Peripheral Neuropathy (DPN) is one of the most common chronic complications of diabetes mellitus, which mainly manifests symmetric pain, numbness, ankylosis, or with abdominal distension, abnormal sweating, and accompanied by glove-sock-like hyperalgesia or loss of sensation as the main symptom, which seriously affects the quality of life of patients. Although drug treatment has some effect, from the overall long-term perspective, long-term medication is easy to produce drug dependence, and often easy to cause ataxia, blurred vision, constipation, diplopia, nausea and other adverse drug reactions. Electroacupuncture treatment for DPN has certain advantages, with clear efficacy and no toxic side effects, and is being increasingly recognised by the public and professionals. The study is designed to observe the therapeutic effect and safety of electroacupuncture (EA) in the treatment of DPN.

NCT ID: NCT06051929 Not yet recruiting - Emotional Distress Clinical Trials

Mechanism of Mindfulness Intervention for Emotional Distress: the Role of Cognitive Flexibility

Start date: October 20, 2023
Phase: N/A
Study type: Interventional

This study hopes to: explore whether offline and online mindfulness interventions can significantly alleviate individual emotional distress and improve cognitive flexibility level. explore whether cognitive flexibility is a mediator in mindfulness intervention to alleviate emotional distress, and to meet the principles of mechanism.